- Home
- Equipment
- vatican city
- progressive liver disease
Show results for
Refine by
Applications
- Clinical Immunology and Intensive Care Medicine for Haemophilia
- Clinical Immunology and Intensive Care Medicine for Immunoglobulins
- Clinical Immunology and Intensive Care Medicine for Antibody Deficiency
- MouthLab - Mobile Monitoring System for Biopharmaceutical
- MouthLab - Mobile Monitoring System for Contract Research Organizations (CROs)
Progressive Liver Disease Equipment & Supplies In Vatican City
87 equipment items found
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 years. It is the most effective, safe and well tolerated drug available to this end. However, patients ...
Manufactured by:Sanrai International based inEndicott, NEW YORK (USA)
The Inogen G5 is the smallest, most powerful six setting portable oxygen concentrator available in the world today. It is the latest portable oxygen concentrator to be launched. Offering 1 to 6 flow settings, the G5 is one of the most powerful, lightest, and quietest units available to the oxygen user today. The G5 has the highest oxygen output of any portable device on the market. As COPD is a ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. Discover the articles we published in Scientific Reports: Relizani et al. 2022 and Kropp et al. 2021. ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
Manufactured by:Notal Vision, Inc. based inManassas, VIRGINIA (USA)
A home-based monitoring program supporting earlier detection of wet AMD in intermediate dry AMD patients. FDA-Cleared and Covered by Medicare and Most Private Insurance. The progression from dry Age-related Macular Degeneration (AMD) to wet AMD can occur rapidly and lead to severe vision loss if left undiagnosed and untreated. ForeseeHome® allows physicians to detect wet AMD earlier, and help ...
Manufactured by:Aidar Health based inBaltimore, MARYLAND (USA)
MouthLab is a non-invasive, hand-held. Rapid Health Assessment device that is designed to be used at home. It is cost-effective and as easy to use as a digital thermometer, yet capable of measuring multiple vital health parameters in under 80 ...
Manufactured by:Biotest AG based inDreieich, GERMANY
Trimodulin is an innovative polyvalent antibody composition, purified from human plasma. In comparison to standard IgG preparations (IVIG), trimodulin contains relevant amounts of IgM and IgA in addition to ...
Manufactured by:MeMed based inTirat Carmel, ISRAEL
Some infections resolve quickly, while others lead to severe immune dysregulation, respiratory failure and death. Distinguishing between the two is challenging.MeMed COVID-19 Severity builds on an extensive body of evidence supporting the role of viral-induced TRAIL and IP-10 and inflammatory CRP proteins in severe SARS-CoV-2 infection. From a small serum sample, MeMed COVID-19 Severity ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Strong scientific and clinical rationale for PAD4 inhibitors in autoimmune ...
Manufactured by:Guangzhou Wondfo Biotech Co., Ltd. based inGuangzhou, CHINA
RBD (receptor binding domain) of 2019-nCoV virus S1 protein is the region that binds to the ACE2 receptor on human cells as the first step of virus invading. The majority and most potency neutralizing antibody targets the epitopes on RBD, therefore can be detected using RBD antibody ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
Quick progression of cyst formation in the distal segment of the ...
Manufactured by:Oxford Gene Technology IP Limited based inOxford, UNITED KINGDOM
The P53 probe mix consists of a 161kb probe, labelled in red that covers the whole P53 (TP53) gene and the flanking regions. The probe mix also contains a control probe for the 17 centromere (D17Z1) that is labelled in ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
Slow progression with cysts in all segments of the ...
Manufactured by:Quanterix Corporation based inBillerica, MASSACHUSETTS (USA)
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels. For the first time, oncology and ...
Manufactured by:Darnitsa Group based inKyiv, UKRAINE
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol. The primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic low-density lipoprotein (LDL) receptors on the cell ...
by:Kephera Diagnostics, LLC based inFramingham, MASSACHUSETTS (USA)
Kephera is developing a new test for Lyme disease, supported by a grant from the National Institute of Allergy and Infectious Diseases. Lyme disease has become the most common vector-borne disease in the U.S., with over 300,000 cases per year estimated by epidemiologists. It is a risk throughout large parts of the U.S., northern Europe and Asia. Lyme disease presents a diagnostic challenge due ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction worth up to $670 ...
Manufactured by:LimFlow, Inc. based inSan Jose, CALIFORNIA (USA)
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is characterized by non-healing foot ulcers that considerably lessen mobility and quality of ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Pelabresib (CPI-0610) is an investigational selective small-molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. The compound has demonstrated a wide therapeutic window, with activity seen at a 48 mg dose in a lymphoma study and with a maximum ...
by:AdAlta Limited based inBundoora, AUSTRALIA
A specific form of lung fibrosis is Idiopathic pulmonary fibrosis (IPF), which is a chronic and ultimately fatal disease, where tissue deep in the lungs becomes scarred, over time, resulting in a progressive decline in lung function and shortness of breath. There is currently no cure for IPF with most people living only three to five years after diagnosis. The rate at which the disease progresses ...